11
Doximity (DOCS) Crushes Q2 Revenue Estimates — What’s Next?
Doximity (DOCS) Q2 2026 Earnings: The Simple Breakdown
TL;DR: Doximity beat revenue expectations but missed on profit per share. The company raised its full-year sales forecast but lowered its profit forecast. Growth is slowing down, but the business is still very efficient at getting new customers.
What Is Doximity?
Imagine a LinkedIn just for doctors. That’s Doximity.
- Over 80% of U.S. physicians use it
- Doctors use it to collaborate, read medical news, manage careers, and do virtual patient visits
- It makes money by selling subscriptions and advertising to hospitals, drug companies, and recruiters who want to reach those doctors
- Stock ticker: NYSE: DOCS
- Market value: $3.89 billion
Q2 2026 Scorecard: The Key Numbers
| Metric | Actual | Expected | Verdict |
|---|---|---|---|
| Revenue | $156.6M | $151.3M | Beat by 3.5% |
| Adjusted EPS (Profit per share) | $0.29 | $0.30 | Miss by 4.2% |
| Adjusted EBITDA | $74.77M | $69.59M | Beat by 7.4% |
| EBITDA Margin | 47.7% | — | Very healthy |
| Billings | $159.3M | — | Up 7% YoY |
Quick Vocabulary
- EPS (Earnings Per Share): Profit divided by number of shares. "Adjusted" means they removed one-time items to show ongoing performance.
- EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization. A way to measure operating profit without accounting tricks.
- Billings: Cash actually collected from customers this quarter. Different from revenue, which is recognized slowly over contract periods.
- YoY: Year-over-Year (comparing to same quarter last year).
The Good News
1. Revenue Beat Expectations
- $156.6M vs. $151.3M expected
- 7.3% growth year-over-year
- Management raised full-year revenue guidance to $676M (was $670M)
2. EBITDA Crushed Estimates
- $74.77M vs. $69.59M expected
- 47.7% margin = keeps nearly $0.48 of every dollar as operating profit
3. Incredibly Efficient Customer Acquisition
- CAC Payback Period: 6 months
- Translation: They earn back what they spend to get a new customer in just half a year
- This means they could spend more on marketing to grow faster if they wanted to
4. Strong Long-Term Track Record
- 5-year annual growth rate: 21.9% (beats average software company)
- 2-year annual growth rate: 15.2% (still respectable)
The Not-So-Good News
1. Profit Per Share Missed
- $0.29 vs. $0.30 expected
- Small miss, but still a miss
2. Profitability Is Declining Fast
| Margin | This Quarter | Year Ago / Last Quarter | Change |
|---|---|---|---|
| Operating Margin | 21.5% | 37.4% (year ago) | -16 points |
| Free Cash Flow Margin | 25.3% | 73.8% (last quarter) | -48 points |
Important Callout
Free Cash Flow Margin dropped from 73.8% to 25.3% in just one quarter. That’s a massive decline. It means the company is keeping far less cash from each dollar of sales. This could be due to timing (when they pay bills vs. collect cash) or increased investment—but it’s worth watching closely.
3. Full-Year Profit Guidance Cut
- EBITDA guidance: $319M midpoint
- Analysts expected $329.2M
- Management sees lower profitability for the full year than Wall Street hoped
4. Growth Is Slowing Down Significantly
| Period | Growth Rate |
|---|---|
| 5-year average | 21.9% |
| 2-year average | 15.2% |
| This quarter (YoY) | 7.3% |
| Next quarter guidance | 1.2% |
| Analysts’ next 12 months | 3.6% |
Reality Check: Growth has decelerated from ~22% to ~7% to potentially ~1-3%. This is a mature company now, not a high-growth startup.
5. Billings Growing Slower Than Revenue
- Billings growth (4-quarter avg): 7.9%
- Revenue growth: higher
- Why it matters: They’re recognizing revenue faster than collecting cash. This can signal:
- Customers paying more slowly
- Contract terms changing
- Potential future revenue slowdown
What Management Is Saying
Next Quarter Guidance:
- Revenue: ~$170.5M (≈1.2% YoY growth)
- Essentially flat growth expected
Full Year Guidance:
- Revenue: $676M midpoint (raised from $670M)
- EBITDA: $319M midpoint (below $329M estimates)
The Big Picture: Should You Care?
The Bull Case (Reasons to Be Optimistic)
- Dominant network: 80%+ of US doctors = massive moat
- High margins: 47.7% EBITDA margin is excellent
- Super efficient: 6-month CAC payback = can accelerate growth if needed
- Raised revenue guidance: Confidence in top line
- Recurring revenue model: Subscriptions = predictable income
The Bear Case (Reasons to Be Cautious)
- Growth collapsing: From 22% → 7% → 1-3% is a steep curve
- Margins compressing: Operating margin cut in half YoY
- Cash flow deteriorating: FCF margin down 48 points QoQ
- Profit guidance cut: Full-year EBITDA below expectations
- Billings < Revenue: Potential signal of future slowdown
The Verdict from the Article
"Overall, this quarter could have been better. The stock remained flat at $20.71 immediately following the results."
The market yawned. Neither a disaster nor a celebration.
Summary: What You Need to Know
| Strengths | Watch Items |
|---|---|
| Beat revenue & EBITDA estimates | Missed EPS estimate |
| Raised full-year revenue guide | Cut full-year EBITDA guide |
| 80%+ US doctor penetration | Growth rapidly decelerating |
| 47.7% EBITDA margin | Operating margin halved YoY |
| 6-month CAC payback (elite) | FCF margin crashed QoQ |
| $3.89B market cap, profitable | Billings growing slower than revenue |
Bottom Line: Doximity is a profitable, cash-generating monopoly in its niche. But it’s transitioning from "growth stock" to "mature compounder." The question for investors: Is the current price right for a company growing 3-7% with declining margins?
FAQ: Your Questions Answered
1. What does "CY2026" mean?
CY = Calendar Year. Doximity’s fiscal year matches the calendar year. Q2 CY2026 = April–June 2026.
2. Why did revenue beat but EPS miss?
Revenue was higher than expected, but costs were also higher (or taxes/interest differed), so profit per share came in slightly below estimates. The company is investing more—possibly in sales, marketing, or product development.
3. Is a 6-month CAC payback really that good?
Yes, it’s exceptional. Most SaaS companies aim for 12–18 months. 6 months means Doximity gets its marketing money back very fast, giving it flexibility to grow aggressively if it chooses.
4. Why did Free Cash Flow Margin drop so much in one quarter?
Could be timing differences (e.g., paid big annual bills this quarter, collect cash next quarter), increased capital expenditures, or working capital changes. One quarter isn’t a trend—but two quarters of this would be a red flag.
5. Should I buy DOCS stock now?
This article doesn’t give investment advice. The original source says: "The latest quarter is just one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy." Check their full research report (linked in the original) for a deeper valuation analysis.
Data sourced from Doximity Q2 CY2026 earnings release and StockStory analysis. All figures in USD. This summary is for educational purposes only—not financial advice.
